Horizon Therapeutics Common
|
14.3 |
$828M |
|
9.0M |
92.04 |
Mirati Therapeutics Common
|
13.8 |
$801M |
|
4.7M |
171.30 |
United Therapeutics Corp Common
(UTHR)
|
8.7 |
$502M |
|
3.0M |
167.27 |
Acceleron Pharma Common
|
7.0 |
$407M |
|
3.0M |
135.61 |
Vertex Pharmaceuticals Common
(VRTX)
|
5.2 |
$301M |
|
1.4M |
214.89 |
Arena Pharmaceuticals Common
|
4.9 |
$281M |
|
4.1M |
69.39 |
Argenx Se Sponsored ADR
(ARGX)
|
4.4 |
$255M |
|
926k |
275.39 |
Iovance Biotherapeutics Common
(IOVA)
|
4.4 |
$253M |
|
8.0M |
31.66 |
Ascendis Pharma Sponsored ADR
|
4.2 |
$245M |
|
1.9M |
128.88 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.9 |
$167M |
|
1.4M |
116.97 |
Sarepta Therapeutics Common
(SRPT)
|
2.8 |
$160M |
|
2.2M |
74.53 |
Biomarin Pharmaceutical Common
(BMRN)
|
2.2 |
$125M |
|
1.7M |
75.51 |
Amicus Therapeutics Common
(FOLD)
|
2.1 |
$121M |
|
12M |
9.88 |
Kura Oncology Common
(KURA)
|
2.0 |
$113M |
|
4.0M |
28.27 |
Mersana Therapeutics Common
(MRSN)
|
1.9 |
$110M |
|
6.8M |
16.18 |
Adverum Biotechnologies Common
|
1.4 |
$79M |
|
8.0M |
9.86 |
Pmv Pharmaceuticals Common
(PMVP)
|
1.3 |
$78M |
|
2.4M |
32.89 |
Constellation Pharmaceuticals Common
|
1.2 |
$69M |
|
3.0M |
23.39 |
Xenon Pharmaceuticals Common
(XENE)
|
1.1 |
$65M |
|
3.7M |
17.90 |
Acadia Pharmaceuticals Common
(ACAD)
|
1.1 |
$65M |
|
2.5M |
25.80 |
Trillium Therapeutics Common
|
1.1 |
$61M |
|
5.7M |
10.74 |
Syndax Pharmaceuticals Common
(SNDX)
|
1.0 |
$56M |
|
2.5M |
22.36 |
Relmada Therapeutics Common
(RLMD)
|
0.9 |
$54M |
|
1.5M |
35.21 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.9 |
$50M |
|
3.2M |
15.48 |
Praxis Precision Medicines Common
|
0.8 |
$47M |
|
1.6M |
29.72 |
Cymabay Therapeutics Common
|
0.8 |
$47M |
|
10M |
4.54 |
Iveric Bio Common
|
0.8 |
$45M |
|
7.3M |
6.18 |
Apellis Pharmaceuticals Common
(APLS)
|
0.7 |
$43M |
|
1.0M |
42.91 |
Deciphera Pharmaceuticals Common
|
0.7 |
$40M |
|
893k |
44.84 |
Design Therapeutics Common
(DSGN)
|
0.7 |
$40M |
|
1.5M |
27.04 |
Avadel Pharmaceuticals Sponsored ADR
|
0.7 |
$40M |
|
4.4M |
9.04 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.6 |
$37M |
|
6.0M |
6.21 |
Travere Therapeutics Common
(TVTX)
|
0.5 |
$31M |
|
1.2M |
24.97 |
Mannkind Corp Common
(MNKD)
|
0.5 |
$29M |
|
7.5M |
3.92 |
Olema Pharmaceuticals Common
(OLMA)
|
0.4 |
$25M |
|
877k |
28.05 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
0.3 |
$19M |
|
3.6M |
5.31 |
Relay Therapeutics Common
(RLAY)
|
0.3 |
$17M |
|
500k |
34.57 |
Merus N V Common
(MRUS)
|
0.2 |
$14M |
|
665k |
20.89 |
Genocea Biosciences Common
(GNCAQ)
|
0.2 |
$14M |
|
5.1M |
2.71 |
Avidity Biosciences Common
(RNA)
|
0.2 |
$12M |
|
545k |
21.81 |
Black Diamond Therapeutics Common
(BDTX)
|
0.2 |
$11M |
|
440k |
24.26 |
Therapeutics Acquisition Corp Common
|
0.2 |
$11M |
|
1.0M |
10.51 |
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$10M |
|
1.7M |
6.21 |
Bctg Acquisition Corp Common
|
0.2 |
$8.9M |
|
800k |
11.12 |
Jounce Therapeutics Common
|
0.1 |
$5.7M |
|
555k |
10.27 |
Galapagos Nv Sponsored ADR
(GLPG)
|
0.0 |
$239k |
|
3.1k |
77.10 |